As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.
Sign in to download the full article
William Wijns1; Mathias Vrolix2; Stefan Verheye3; Danny Schoors4; Ton Slagboom5; Marcel Gosselink6; Edouard Bénit7; David Kandzari8; Dennis Donohoe9; John Ormiston10;
1. National University of Ireland Galway, Lambe Institute, Galway, IRELAND; 2. Zienkenhuis Oost-Limburg, Genk, Belgium; 3. Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium; 4. Brussels University Hospital, Brussels, Belgium; 5. Onze Lieve Vrouw Gasthuis, Amsterdam, the Netherlands; 6. Isala Klinieken, Zwolle, the Netherlands; 7. Heart Center Hasselt, Jessaziekenhuis, Hasselt, Belgium; 8. Piedmont Heart Institute, Atlanta, GA, USA; 9. Micell Technologies, Durham, NC, USA; 10. Mercy Angiography Unit, Auckland, New Zealand
Aims: The aim was to evaluate the five-year clinical results of a sirolimus-eluting stent (MiStent SES) with a bioabsorbable coating designed for sustained drug delivery during and after rapid polymer dissolution.
Methods and results: The five-year resul…